What Types of Cancer Could Benefit from Smac Mimetics?
Research has shown that Smac mimetics have potential in treating a wide range of cancers. These include hematological malignancies like multiple myeloma and acute myeloid leukemia, as well as solid tumors such as melanoma, breast cancer, prostate cancer, and lung cancer. Clinical trials are ongoing to determine the efficacy and safety of Smac mimetics in these and other cancer types.
